SCHEMBL2804255

SCHEMBL2804255

c1c[nH]c(-c2ncncn2)c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 1/20 0.40
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ IKBKE Q14164 1/20 0.33
▸ TBK1 Q9UHD2 1/20 0.33
▸ TGFBR1 P36897 1/20 0.31
▸ HSF1 Q00613 1/20 0.31
▸ ABCB1 P08183 1/20 0.31
▸ ABCG2 Q9UNQ0 1/20 0.31
▸ KDR P35968 2/20 0.30
▸ ADRA1D P25100 1/20 0.30
▸ ADRA1A P35348 1/20 0.30
▸ ADRA1B P35368 1/20 0.30
▸ HSP90AA1 P07900 1/20 0.30
▸ AURKA O14965 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29030223 0.84 HDAC1 (0.46) KDM4CHDAC1HDAC6CDK5CDK5R1
SCHEMBL442421 0.81 KDM4C (0.46) KDM4CHDAC1HDAC6CDK5CDK5R1
SCHEMBL4567241 0.77 KDM4C (0.44) KDM4CCDK5CDK5R1IKBKETBK1
SCHEMBL17694181 0.75 KDM4C (0.40) KDM4CHDAC1HDAC6CDK5CDK5R1
SCHEMBL23416935 0.74 KDM4C (0.38) KDM4CHDAC1HDAC6CDK5CDK5R1
SCHEMBL15219273 0.74 KDM4C (0.38) KDM4CHDAC1HDAC6CDK5CDK5R1
SCHEMBL29030222 0.72 ADORA2A (0.38) KDM4CABCB1ABCG2KDR
SCHEMBL630634 0.71 HDAC6 (0.41) KDM4CHDAC1HDAC6CDK5CDK5R1
SCHEMBL1192472 0.70 PDPK1 (0.46) KDM4CHDAC1HDAC6IKBKETBK1
SCHEMBL11916028 0.70 KDM4C (0.35) KDM4CHDAC1HDAC6CDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080253978-A1 Derivatives of Pyrrolyltriazine Together with Methods for Obtaining Them and Their Use as Protecting Agents Uv Radiation ISDIN, S.A. (ES) 2008-10-16 — — US claimed
WO-2008067928-A1 UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE ISDIN S.A. (ES) 2008-06-12 — — WO claimed
EP-1891050-A1 NEW DERIVATIVES OF PYRROLYLTRIAZINE TOGETHER WITH METHODS FOR OBTAINING THEM AND THEIR USE AS PROTECTING AGENTS AGAINST UV RADIATION ISDIN, S.A. (ES) 2008-02-27 — — EP claimed
WO-2006128920-A1 NEW DERIVATIVES OF PYRROLYLTRIAZINE TOGETHER WITH METHODS FOR OBTAINING THEM AND THEIR USE AS PROTECTING AGENTS AGAINST UV RADIATION ISDIN, S.A. (ES) 2006-12-07 — — WO claimed
WO-2006128791-A1 NEW DERIVATIVES OF PYRROLYLTRIAZINE TOGETHER WITH METHODS FOR OBTAINING THEM AND THEIR USE AS PROTECTING AGENTS AGAINST UV RADIATION ISDIN, S.A. (ES) 2006-12-07 — — WO claimed
EP-0421266-A1 Azolylpyrimidine- and -triazine derivatives and agents containing them BASF Aktiengesellschaft (DE) 1991-04-10 — — EP claimed
CN-110156824-A Organic luminescent compounds and its application and organic electroluminescence device 北京绿人科技有限责任公司 2019-08-23 — — CN disclosed
US-9812315-B2 Treating solution for electronic parts, and process for producing electronic parts FINE POLYMERS CORPORATION (JP) 2017-11-07 — — US disclosed
US-20150279654-A1 TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS FINE POLYMERS CORPORATION (JP) 2015-10-01 — — US disclosed
EP-2241312-A1 Use of compositions comprising urea for treating microbial infections ISDIN S.A. (ES) 2010-10-20 — — EP disclosed
EP-2153814-A1 Use of compositions comprising urea ISDIN S.A. (ES) 2010-02-17 — — EP disclosed
EP-2153815-A1 Use of urea containing compositions ISDIN S.A. (ES) 2010-02-17 — — EP disclosed
EP-1753764-B1 PYRROLOPYRIDINE DERIVATIVES GLAXO GROUP LTD (GB) 2008-10-29 — — EP disclosed
EP-1891050-A1 NEW DERIVATIVES OF PYRROLYLTRIAZINE TOGETHER WITH METHODS FOR OBTAINING THEM AND THEIR USE AS PROTECTING AGENTS AGAINST UV RADIATION ISDIN, S.A. (ES) 2008-02-27 — — EP disclosed
WO-2006128920-A1 NEW DERIVATIVES OF PYRROLYLTRIAZINE TOGETHER WITH METHODS FOR OBTAINING THEM AND THEIR USE AS PROTECTING AGENTS AGAINST UV RADIATION ISDIN, S.A. (ES) 2006-12-07 — — WO disclosed
WO-2006128920-A1 NEW DERIVATIVES OF PYRROLYLTRIAZINE TOGETHER WITH METHODS FOR OBTAINING THEM AND THEIR USE AS PROTECTING AGENTS AGAINST UV RADIATION ISDIN, S.A. (ES) 2006-12-07 — — WO disclosed
WO-2006128791-A1 NEW DERIVATIVES OF PYRROLYLTRIAZINE TOGETHER WITH METHODS FOR OBTAINING THEM AND THEIR USE AS PROTECTING AGENTS AGAINST UV RADIATION ISDIN, S.A. (ES) 2006-12-07 — — WO disclosed
WO-2006128791-A1 NEW DERIVATIVES OF PYRROLYLTRIAZINE TOGETHER WITH METHODS FOR OBTAINING THEM AND THEIR USE AS PROTECTING AGENTS AGAINST UV RADIATION ISDIN, S.A. (ES) 2006-12-07 — — WO disclosed
EP-0421266-A1 Azolylpyrimidine- and -triazine derivatives and agents containing them BASF Aktiengesellschaft (DE) 1991-04-10 — — EP disclosed
EP-0421266-A1 Azolylpyrimidine- and -triazine derivatives and agents containing them BASF Aktiengesellschaft (DE) 1991-04-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080253978-A1 Derivatives of Pyrrolyltriazine Together with Methods for Obtaining Them and Their Use as Protecting Agents Uv Radiation UNG, TPMT, PPOX KDM4C 2361/4885HDAC1 3056/4885HDAC6 2724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback